RETA | Reata Pharmaceuticals Inc Category: Consumer goods Quick infos Headquarters: Irving, Texas, United States Trade prices Volume: Market Cap: 3.56B Prev closed: 138.63 Open: 138.74 High: 144.68 Low: 131.76 52 week low: 76.34 52 week high: 186.82 Dividends: No Dividends Next ER: November 8, 2021
About the Company
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, ...
Date EPS / Forecast Revenue / Forecast November 15, 2021 August 9, 2021 -2 / -1.88 2.22M / 1.25M Beat! May 6, 2021 -1.86 / -2.09 944K / 1.43M Beat! March 1, 2021 -1.9 / -2.16 3.19M / 1.45M Beat! November 9, 2020 -1.94 / -2.03 1.4M / 1.79M view more Historical Data
Date Price Open High Low Vol Change ER Oct 8, 2021 98.99 98.04
98.83K 1.29% Oct 7, 2021 97.73 97.00
167.40K 1.24% Oct 6, 2021 96.53 98.00
156.27K -2.26% Oct 5, 2021 98.76 101.45
159.66K -2.57% Oct 4, 2021 101.37 103.09
210.99K -2.52% Oct 1, 2021 103.99 100.47
276.05K 3.36% Sep 30, 2021 100.61 106.00
354.97K -4.48% Sep 29, 2021 105.33 108.17
96.52K -1.51% Sep 28, 2021 106.95 111.13
142.08K -4.82% Sep 27, 2021 112.37 110.28
118.55K 2.37% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded: 2002 Employees: 123 News Reata requests pre-NDA meeting for omaveloxolone in Friedreich’s Ataxia seekingalpha.com May 19, 2021 7:05 pm Cardinal Health downgraded at Baird, Argenx upgraded on potential of gMG therapy; in today’s analyst action seekingalpha.com May 10, 2021 9:29 pm Reata Pharmaceuticals EPS beats by $0.30, misses on revenue seekingalpha.com May 6, 2021 6:45 pm Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mesoblast, Loop Industries, Turquoise Hill Resources, and Reata Pharmaceuticals and Encourages Investors to Contact the Firm finance.yahoo.com Nov 25, 2020 8:00 pm Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Loop Industries, Turquoise Hill Resources, Reata Pharmaceuticals, and Evolus and Encourages Investors to Contact the Firm finance.yahoo.com Nov 25, 2020 8:00 pm ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - RETA finance.yahoo.com Nov 25, 2020 7:59 pm Reata Pharmaceuticals, Inc. (RETA) Q3 2020 Earnings Call Transcript fool.com Nov 25, 2020 4:30 pm Reata Pharmaceuticals Q1 2021 Earnings Preview seekingalpha.com May 6, 2021 1:07 am FDA accepts Reata's chronic kidney disease treatment bardoxolone NDA for review seekingalpha.com Apr 27, 2021 5:03 am Reata shares up ~7% as Barclays sees promise in lead candidate bardoloxone seekingalpha.com Apr 26, 2021 10:19 pm Reata Pharmaceuticals posts Q4 results, cash guidance seekingalpha.com Mar 2, 2021 1:15 am Reata Pharma submits bardoxolone application in U.S. for kidney disease seekingalpha.com Mar 1, 2021 7:42 pm Reata Pharmaceuticals EPS beats by $0.45, beats on revenue seekingalpha.com Mar 1, 2021 7:39 pm Reata Pharmaceuticals Q4 2020 Earnings Preview seekingalpha.com Feb 27, 2021 3:39 am Citing uncertainty, Baird stays neutral on Biotech for 2021 seekingalpha.com Jan 5, 2021 5:40 am Reata Pharmaceuticals under pressure on pricing equity offering seekingalpha.com Dec 2, 2020 6:01 pm Reata Pharma launches 2M-share stock offering seekingalpha.com Dec 2, 2020 5:16 am Reata Announces Publication of Results From Pivotal Moxie Trial of Omaveloxolone in Patients with Friedreichs Ataxia finance.yahoo.com Nov 25, 2020 7:00 pm DEADLINE FOR RETA INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc. finance.yahoo.com Nov 25, 2020 6:42 pm RETA LOSS ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc. finance.yahoo.com Nov 25, 2020 6:19 pm
This company doesn't provide a dividend.
Key Persons CFO : Jason Wilson Chief Medical Officer : Seemi Khan Talk about Reata Pharmaceuticals Inc below in comments section below.
Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
If you are looking for News & events, Press Release, they are available on their Investors Relationssite.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via
Paypal. More features coming soon :) Buy on Amazon
Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis